Europe — EMA
Oncaspar (Pegaspargase)
Pegaspargase, the active ingredient in Oncaspar, is a pegylated L-asparaginase presented as a sterile powder for intravenous use. It is employed in the treatment of acute lymphoblastic leukemia, particularly in…
Request sourcing
What is Pegaspargase?
Pegaspargase, the active ingredient in Oncaspar, is a pegylated L-asparaginase presented as a sterile powder for intravenous use. It is employed in the treatment of acute lymphoblastic leukemia, particularly in pediatric and young adult patients. GNH USA supplies Oncaspar as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.
GNH USA supplies Oncaspar as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.
What is Pegaspargase used for?
Oncaspar is an enzyme‑based ... ... ... ... ... g:
- ** ** ... - .... - …
What are the side effects of Pegaspargase?
S
